Research

Associations between HLA and autoimmune neurological diseases with autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065322/

Learn more
Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better? February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106675/

Learn more
Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351505/

Learn more
Psychiatric Manifestation of Anti-LGI1 Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348933/

Learn more
Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448167/

Learn more
Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404295/

Learn more
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042499/

Learn more
Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094865/

Learn more
18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968877/

Learn more
Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146067/

Learn more